| Report Title | Price | Action |
|---|---|---|
| E3 Ubiquitin Protein Ligase CBL B (Casitas B Lineage Lymphoma Proto Oncogene b or RING Finger Protein 56 or SH3 Binding Protein CBLB or Signal Transduction Protein CBLB or CBLB or EC 2.3.2.27) - Drugs in Development, 2021
E3 Ubiquitin Protein Ligase CBL B (Casitas B Lineage Lymphoma Proto Oncogene b or RING Finger Protein 56 or SH3 Binding Protein CBLB or Signal Transdu...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Parathyroid Hormone/Parathyroid Hormone Related Peptide Receptor (PTH/PTHrP Type I Receptor or Parathyroid Hormone 1 Receptor or PTH1R) - Drugs in Development, 2021
Parathyroid Hormone/Parathyroid Hormone Related Peptide Receptor (PTH/PTHrP Type I Receptor or Parathyroid Hormone 1 Receptor or PTH1R) - Drugs in Dev...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Cells Expressing Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021
Cells Expressing Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021 Summar...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Systolic Heart Failure (Cardiovascular) - Drugs in Development, 2021
Systolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 Summary Systolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Meningioma (Oncology) - Drugs in Development, 2021
Meningioma (Oncology) - Drugs in Development, 2021 Summary Meningioma (Oncology) - Drugs in Development, 2021 provides an overview of the Meningioma...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 | |
| Non-Small Cell Lung Carcinoma (Oncology) - Drugs in Development, 2021
Non-Small Cell Lung Carcinoma (Oncology) - Drugs in Development, 2021 Summary Non-Small Cell Lung Carcinoma (Oncology) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 110
|
$ 2000 | |
| Articular Cartilage Defect (Musculoskeletal) - Drugs in Development, 2021
Articular Cartilage Defect (Musculoskeletal) - Drugs in Development, 2021 Summary Articular Cartilage Defect (Musculoskeletal) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Epithelial Discoidin Domain Containing Receptor 1 (CD167 Antigen Like Family Member A or Mammary Carcinoma Kinase 10 or Protein Tyrosine Kinase 3A or Protein Tyrosine Kinase RTK 6 or Tyrosine Protein Kinase CAK or CD167a or DDR1 or EC 2.7.10.1) - Drugs in Development, 2021
Epithelial Discoidin Domain Containing Receptor 1 (CD167 Antigen Like Family Member A or Mammary Carcinoma Kinase 10 or Protein Tyrosine Kinase 3A or ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Phosphodiesterase 3 (PDE3 or EC 3.1.4.17) - Drugs in Development, 2021
Phosphodiesterase 3 (PDE3 or EC 3.1.4.17) - Drugs in Development, 2021 Summary Phosphodiesterase 3 (PDE3 or EC 3.1.4.17) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Cells Expressing Folate Receptor (FOLR) - Drugs in Development, 2021
Cells Expressing Folate Receptor (FOLR) - Drugs in Development, 2021 Summary Cells Expressing Folate Receptor (FOLR) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Hepatic Injury (Gastrointestinal) - Drugs in Development, 2021
Hepatic Injury (Gastrointestinal) - Drugs in Development, 2021 Summary Hepatic Injury (Gastrointestinal) - Drugs in Development, 2021 provides an ov...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Brain Hemorrhage (Central Nervous System) - Drugs in Development, 2021
Brain Hemorrhage (Central Nervous System) - Drugs in Development, 2021 Summary Brain Hemorrhage (Central Nervous System) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Ocular Inflammation (Ophthalmology) - Drugs in Development, 2021
Ocular Inflammation (Ophthalmology) - Drugs in Development, 2021 Summary Ocular Inflammation (Ophthalmology) - Drugs in Development, 2021 provides a...
Published: Apr-2021 | No. of Pages: 85
|
$ 2000 | |
| Bacillus Anthracis Infections (Infectious Disease) - Drugs in Development, 2021
Bacillus Anthracis Infections (Infectious Disease) - Drugs in Development, 2021 Summary Bacillus Anthracis Infections (Infectious Disease) - Drugs i...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Gap Junction Alpha 1 Protein (Connexin 43 or Gap Junction 43 Kda Heart Protein or GJA1) - Drugs in Development, 2021
Gap Junction Alpha 1 Protein (Connexin 43 or Gap Junction 43 Kda Heart Protein or GJA1) - Drugs in Development, 2021 Summary Gap Junction Alpha 1 Pr...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Retinoic Acid Receptor (RAR) - Drugs in Development, 2021
Retinoic Acid Receptor (RAR) - Drugs in Development, 2021 Summary Retinoic Acid Receptor (RAR) - Drugs in Development, 2021 provides in depth analys...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Cells Expressing Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021
Cells Expressing Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021 Summary Cells Expressing Human Papillomavirus Protein E7 (E7) - D...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Hemophilia (Hematological Disorders) - Drugs in Development, 2021
Hemophilia (Hematological Disorders) - Drugs in Development, 2021 Summary Hemophilia (Hematological Disorders) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) (Central Nervous System) - Drugs in Development, 2021
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) (Central Nervous System) - Drugs in Development, 2021 Summary Dravet Syndrome (Severe Myoclon...
Published: Apr-2021 | No. of Pages: 65
|
$ 2000 | |
| Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021
Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021 Summary Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Deve...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 |